Ziegler-Heitbrock, Loems http://orcid.org/0000-0003-1477-6689
Ohteki, Toshiaki http://orcid.org/0000-0002-8088-5165
Ginhoux, Florent http://orcid.org/0000-0002-2857-7755
Shortman, Ken
Spits, Hergen http://orcid.org/0000-0003-3269-8338
Article History
First Online: 23 March 2023
Competing interests
: H.S. is a consultant for GlaxoSmithKline. The other authors declare no competing interests.